NCT06830850
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06830850
Title A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Atridia Pty Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
GenesisCare North Shore (Oncology) RECRUITING Sydney New South Wales Australia Details
Sydney Adventist Hospital RECRUITING Sydney New South Wales Australia Details
Cancer Research SA RECRUITING Adelaide South Australia Australia Details
Southern Oncology Clinical Research Unit RECRUITING Adelaide South Australia Australia Details
Icon Cancer Centre South Brisbane RECRUITING Brisbane Australia Details
John Flynn Private Hospital RECRUITING Brisbane Australia Details
Eastern Health (Box Hill Hospital) RECRUITING Melbourne Australia Details
Linear Clinical Research Ltd RECRUITING Perth Australia Details
Macquarie University RECRUITING Sydney Australia Details
MUPharm Pty Limited trading as Macquarie University Hospital Pharmacy RECRUITING Sydney Australia Details
Illawarra Shoalhaven Local Health District (Wollongong Hospital) RECRUITING Wollongong Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field